Aclarion Quick Ratio 2021-2024 | ACON
Aclarion Quick Ratio Historical Data | |||
---|---|---|---|
Date | Current Assets - Inventory | Current Liabilities | Quick Ratio |
2024-12-31 | $0.00B | $0.00B | 0.00 |
2024-09-30 | $0.00B | $0.00B | 0.00 |
2024-06-30 | $0.00B | $0.00B | 0.00 |
2024-03-31 | $0.00B | $0.00B | 0.00 |
2023-12-31 | $0.00B | $0.00B | 0.00 |
2023-09-30 | $0.00B | $0.00B | 0.00 |
2023-06-30 | $0.00B | $0.00B | 0.00 |
2023-03-31 | $0.00B | $0.00B | 0.00 |
2022-12-31 | $0.00B | $0.00B | 0.00 |
2022-09-30 | $0.00B | $0.00B | 0.00 |
2022-06-30 | $0.00B | $0.00B | 0.00 |
2022-03-31 | $0.00B | $0.01B | 0.00 |
2021-12-31 | $0.00B | $0.01B | 0.00 |
2021-09-30 | $0.00B | 0.00 | |
2021-06-30 | $0.00B | 0.00 | |
2021-03-31 | $0.00B | 0.00 | |
2020-12-31 | $0.00B | $0.01B | 0.00 |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $0.004B | $0.000B |
Aclarion Inc. is a healthcare technology company which leverages Magnetic Resonance Spectroscopy and a proprietary biomarker to optimize clinical treatments. The Company is also researching the application of AI and machine learning platforms to analyze both the raw spectroscopy data and the post-processed signal to evaluate whether AI platforms. Aclarion Inc. is based in SAN MATEO, CA. |